Expression of syndecan-1 in paired samples of normal and malignant breast tissue from postmenopausal women

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3045-3050

  Löfgren, Lars ^a   Sahlin, L ^b   Jiang, S ^b   Von Schoultz, B ^b   Fernstad, R ^a   Skoog, L ^b   Von Schoultz, E ^b  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Androgen receptor; Breast cancer; Syndecan 1

Indexed keywords

ANDROGEN RECEPTOR; PROTEOGLYCAN; SEX HORMONE; SYNDECAN 1;

AGED; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

AGED; BREAST; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; POSTMENOPAUSE; RECEPTORS, ANDROGEN; STROMAL CELLS; SYNDECAN-1; TUMOR MARKERS, BIOLOGICAL;

EID: 35348962056     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Woodward TL, Xie JW and Haslam SZ: The role of mammary stroma in modulating the proliferative response to ovarian hormones in the normal mammary gland. J Mammary Gland Biol Neoplasia 3: 117-131, 1998.
2. Shekhar MP, Pauley R and Heppner G: Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 5: 130-135, 2003.
3. Delehedde M, Lyon M, Sergeant N, Rahmoune H and Fernig DG: Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J Mammary Gland Biol Neoplasia 6: 253-273, 2001.
4. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I and Watson PH: Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5: R129-135, 2003.
5. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, Galligioni E and Doglioni C: High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 98: 474-483, 2003.
6. Beauvais DM and Rapraeger AC: Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2: 3, 2004.
7. Roskelley CD and Bissell MJ: Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. Biochem Cell Biol 73: 391-397, 1995.
8. Wu X, Pang ST, Sahlin L, Blanck A, Norstedt G and Flores-Morales A: Gene expression profiling of the effects of castration and estrogen treatment in the rat uterus. Biol Reprod 69: 1308-1317, 2003.
9. Stanley MJ, Stanley MW, Sanderson RD and Zera R: Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol 112: 377-383, 1999.
10. Maeda T, Alexander CM and Friedl A: Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells. Cancer Res 64: 612-621, 2004.
11. Leivonen M, Lundin J, Nordling S, von Boguslawski K and Haglund C: Prognostic value of syndecan-1 expression in breast cancer. Oncology 67: 11-18, 2004.
12. Beato M and Klug J: Steroid hormone receptors: an update. Hum Reprod Update 6: 225-236, 2000.
13. Kollara A, Kahn HJ, Marks A and Brown TJ: Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat 67: 245-253, 2001.
14. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ and Trilley WD: Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52: 459-467, 1995.
15. Shan L, Yang Q, Nakamura M, NAkaumara Y, Mori I, Sakurai T and Kakudo K: Active allele loss of the androgen receptor gene contributes to loss of androgen receptor expression in female breast cancers. Biochem Biophys Res Commun 275: 488-492, 2000.
16. Isola JJ: Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170: 31-35, 1993.
17. Löfgren L, Sahlin L, von Schoultz B, Fernstad R, Skoog L and von Schoultz E: Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal women. Acta Oncol 45: 54-60, 2006.
18. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP and Sherman ME: Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13: 1558-1568, 2004.
19. Cheng G, Li Y, Omoto Y, Wang Y, Berg T, Nord M, Vihko P, Warner M, Piao YS and Gustafsson JA: Differential regulation of estrogen receptor (ER)alpha and ERbeta in primate mammary gland. J Clin Endocrinol Metab 90: 435-444, 2005.
20. Leclercq G, Bojar H, Goussard J Nicholson RI, Pichon MF, Piffanelli A, Pousette A, Thorpe S and Lonsdorfer M: Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. Cancer Res 46: 4233s-4236s, 1986.
21. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J and Zako M: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777, 1999.
22. Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD and Korc M: Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61: 5562-5569, 2001.
23. Selim AG, El-Ayat G and Wells CA: Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors. J Clin Pathol 55: 14-16, 2002.
24. Bardin A, Boulle N, Lazennec G, Vignon F and Pujol P: Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11: 537-551, 2004.
25. Santen RJ: Risk of breast cancer with progestins: critical assessment of current data. Steroids 68: 953-964, 2003.
26. Conde I, Alfaro JM, Fraile B, Ruiz A, Paniagua R and Arenas MI: DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status. Breast Cancer Res 6: R140-148, 2004.
27. Makris A, Powles TJ, Allred DC, Ashley S, Ormerod MG, Tiley JC and Dowsett M: Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response. Breast Cancer Res Treat 48: 11-20, 1998.
28. Isaksson E, Wang H, Sahlin L, von Schoultz B, Cline JM and von Schoultz E: Effects of long-term HRT and tamoxifen on the expression of progesterone receptors A and B in breast tissue from surgically postmenopausal cynomolgus macaques. Breast Cancer Res Treat 79: 233-239, 2003.
29. Burak WE Jr, Quinn AL, Farrar WB and Brueggemeier RW: Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase. Breast Cancer Res Treat 44: 57-64, 1997.
30. Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA and Lubahn DB: Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 2: 393-402, 1997.
31. Cooke PS, Buchanan DL, Lubahn DB and Cunha GR: Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse. Biol Reprod 59: 470-475, 1998.